Contact Us | Print Page | Sign In | Register
MS PHENOTYPES - IMPLICATIONS FOR PRACTICE
Tell a Friend About This EventTell a Friend
MS PHENOTYPES - IMPLICATIONS FOR PRACTICE

 Export to Your Calendar 8/7/2019
When: Wednesday, August 7, 2019
7:00 PM
Where: MS PHENOTYPES - IMPLICATIONS FOR PRACTICE
United States

« Go to Upcoming Event List  

MS PHENOTYPES - IMPLICATIONS FOR PRACTICE

 

PRESENTED BY
Fred Lublin, MD 
Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai

 

The MS Clinical subtypes or phenotype descriptions were originally developed in 1996 and updated in 2012 based upon improved knowledge of MS pathology and clinical course. They have been incorporated into clinical practice, used for MS clinical trials and have been part of regulatory review and approval of MS DMTs. In March of 2019,  MS disease course modifiers were added by the FDA to new MS drug labeling.

 

This presentation will explore the 2012 phenotype definitions and modifiers and discuss the practice implications of the new FDA labeling for MS drugs approved for relapsing forms of MS.

 

Register online: https://attendee.gotowebinar.com/register/9068407267640930829 

 

The Consortium of Multiple Sclerosis Centers

3 University Plaza Drive, Suite 116 Hackensack, NJ 07601

Tel: 201.487.1050 | Fax: 862.772.7275

info@mscare.org